Feasibility of diagnosing renal allograft dysfunction by oligonucleotide array: Gene expression profile correlates with histopathology

Transplant Immunology

Volumn 24, Issue 3, 2011, Pages 172-180

  Mao, You ying ^a,d   yang, Hao ^a,d   Wang, Minmin ^a,d   Peng, Wenhan ^a   He, Qiang ^a,c,d   Shou, Zhang fei ^a,c,d   Jiang, Hua ^a   Wu, Jianyong ^a   Fang, Yong qi ^b   Dong, Hai tao ^b   Chen, Jiang hua ^a,c,d  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

^d State administration of traditional Chinese medicine   (China)

Author keywords

Acute allograft rejection; Gene expression; Immune status; Oligonucleotide array; Renal transplant

Indexed keywords

AZATHIOPRINE; CCL1 CHEMOKINE; CD19 ANTIGEN; CXCL13 CHEMOKINE; CYCLOSPORIN A; CYTOCHROME P450 2J2; DACLIZUMAB; MITOGEN ACTIVATED PROTEIN KINASE 7; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ACUTE KIDNEY TUBULE NECROSIS; ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; DOWN REGULATION; FEASIBILITY STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MAST CELL; NON INVASIVE PROCEDURE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL GRAFT DYSFUNCTION; UPREGULATION;

ADOLESCENT; ADULT; B-LYMPHOCYTES; BIOPSY; CHEMOKINE CXCL13; FEMALE; GENE EXPRESSION PROFILING; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; KIDNEY TUBULAR NECROSIS, ACUTE; LEUKOCYTES, MONONUCLEAR; MALE; MAST CELLS; MIDDLE AGED; MONITORING, IMMUNOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 79951511541     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2010.11.008     Document Type: Article

References (37)

1. Kaplan B. Overcoming barriers to long-term graft survival. Am J Kidney Dis 2006, 47:S52-S64.
2. Hoheisel J.D. Microarray technology: beyond transcript profiling and genotype analysis. Nat Rev Genet 2006, 7:200-210.
3. Akalin E., Hendrix R.C., Polavarapu R.G., Pearson T.C., Neylan J.F., Larsen C.P., et al. Gene expression analysis in human renal allograft biopsy samples using high-density oligoarray technology. Transplantation 2001, 72:948-953.
4. Li B., Hartono C., Ding R., Sharma V.K., Ramaswamy R., Qian B., et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001, 344:947-954.
5. Morgun A., Shulzhenko N., Perez-Diez A., Diniz R.V., Sanson G.F., Almeida D.R., et al. Molecular profiling improves diagnoses of rejection and infection in transplanted organs. Circ Res 2006, 98:e74-e83.
6. Mansfield E.S., Sarwal M.M. Arraying the orchestration of allograft pathology. Am J Transplant 2004, 4:853-862.
7. Muthukumar T., Dadhania D., Ding R., Snopkowski C., Naqvi R., Lee J.B., et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005, 353:2342-2351.
8. Lande J.D., Patil J., Li N., Berryman T.R., King R.A., Hertz M.I. Novel insights into lung transplant rejection by microarray analysis. Proc Am Thorac Soc 2007, 4:44-51.
9. Sarwal M., Chua M.S., Kambham N., Hsieh S.C., Satterwhite T., Masek M., et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003, 349:125-138.
10. Flechner S.M., Kurian S.M., Head S.R., Sharp S.M., Whisenant T.C., Zhang J., et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 2004, 4:1475-1489.
11. Tan P.K., Downey T.J., Spitznagel E.L., Xu P., Fu D., Dimitrov D.S., et al. Evaluation of gene expression measurements from commercial microarray platforms. Nucleic Acids Res 2003, 31:5676-5684.
12. Kane M.D., Jatkoe T.A., Stumpf C.R., Lu J., Thomas J.D., Madore S.J. Assessment of the sensitivity and specificity of oligonucleotide (50mer) microarrays. Nucleic Acids Res 2000, 28:4552-4557.
13. Hughes T.R., Mao M., Jones A.R., Burchard J., Marton M.J., Shannon K.W., et al. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nat Biotechnol 2001, 19:342-347.
14. Nielsen P.S., Ohlsson H., Alsbo C., Andersen M.S., Kauppinen S. Expression profiling by oligonucleotide microarrays spotted on coated polymer slides. J Biotechnol 2005, 116:125-134.
15. Barczak A., Rodriguez M.W., Hanspers K., Koth L.L., Tai Y.C., Bolstad B.M., et al. Spotted long oligonucleotide arrays for human gene expression analysis. Genome Res 2003, 13:1775-1785.
16. Mao X., Cai T., Olyarchuk J.G., Wei L. Automated genome annotation and pathway identification using the KEGG Orthology (KO) as a controlled vocabulary. Bioinformatics 2005, 21:3787-3793.
17. Kanehisa M., Goto S., Kawashima S., Okuno Y., Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res 2004, 32:D277-D280.
18. Wu J.Y., Chen J.H., Wang Y.M., He Q., Wu D.B. Improved clinical outcomes in Chinese renal allograft recipients receiving lower dose immunosuppressants. Transplantation 2004, 78:713-718.
19. Mao Y.Y., Chen J.H., Shou Z.F., Wu J.Y., Wang H.P., He Q. Clinical significance of protocol biopsy at one month posttransplantation in deceased-donor renal transplantation. Transpl Immunol 2007, 17:211-214.
20. Solez K., Colvin R.B., Racusen L.C., Sis B., Halloran P.F., Birk P.E., et al. Banff ′05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007, 7:518-526.
21. Fleiner F., Fritsche L., Glander P., Neumayer H.H., Budde K. Reporting of rejection after renal transplantation in large immunosuppressive trials: biopsy-proven, clinical, presumed, or treated rejection?. Transplantation 2006, 81:655-659.
22. Wright G.W., Simon R.M. A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 2003, 19:2448-2455.
23. Yang H., Crawford N., Lukes L., Finney R., Lancaster M., Hunter K.W. Metastasis predictive signature profiles pre-exist in normal tissues. Clin Exp Metastasis 2005, 22:593-603.
24. Clarke R., Ressom H.W., Wang A., Xuan J., Liu M.C., Gehan E.A., et al. The properties of high-dimensional data spaces: implications for exploring gene and protein expression data. Nat Rev Cancer 2008, 8:37-49.
25. Yi M., Horton J.D., Cohen J.C., Hobbs H.H., Stephens R.M. WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data. BMC Bioinform 2006, 7:30.
26. Draghici S., Khatri P., Tarca A.L., Amin K., Done A., Voichita C., et al. A systems biology approach for pathway level analysis. Genome Res 2007, 17:1537-1545.
27. Bunnag S., Einecke G., Reeve J., Jhangri G.S., Mueller T.F., Sis B., et al. Molecular correlates of renal function in kidney transplant biopsies. J Am Soc Nephrol 2009, 20:1149-1160.
28. Gunther O.P., Balshaw R.F., Scherer A., Hollander Z., Mui A., Triche T.J., et al. Functional genomic analysis of peripheral blood during early acute renal allograft rejection. Transplantation 2009, 88:942-951.
29. Reeve J., Einecke G., Mengel M., Sis B., Kayser N., Kaplan B., et al. Diagnosing rejection in renal transplants: a comparison of molecular- and histopathology-based approaches. Am J Transplant 2009, 9:1802-1810.
30. Lockhart D.J., Dong H., Byrne M.C., Follettie M.T., Gallo M.V., Chee M.S., et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996, 14:1675-1680.
31. Schena M., Shalon D., Davis R.W., Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995, 270:467-470.
32. Perou C.M., Jeffrey S.S., van de Rijn M., Rees C.A., Eisen M.B., Ross D.T., et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 1999, 96:9212-9217.
33. El Atifi M., Dupre I., Rostaing B., Chambaz E.M., Benabid A.L., Berger F. Long oligonucleotide arrays on nylon for large-scale gene expression analysis. Biotechniques 2002, 33:612-618.
34. Brennan C., Zhang Y., Leo C., Feng B., Cauwels C., Aguirre A.J., et al. High-resolution global profiling of genomic alterations with long oligonucleotide microarray. Cancer Res 2004, 64:4744-4748.
35. DeVries M.E., Hosiawa K.A., Cameron C.M., Bosinger S.E., Persad D., Kelvin A.A., et al. The role of chemokines and chemokine receptors in alloantigen-independent and alloantigen-dependent transplantation injury. Semin Immunol 2003, 15:33-48.
36. Steinmetz O.M., Panzer U., Kneissler U., Harendza S., Lipp M., Helmchen U., et al. BCA-1/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection. Kidney Int 2005, 67:1616-1621.
37. de Vries V.C., Wasiuk A., Bennett K.A., Benson M.J., Elgueta R., Waldschmidt T.J., et al. Mast cell degranulation breaks peripheral tolerance. Am J Transplant 2009, 9:2270-2280.